Cutler Group’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$2K Buy
2,100
+800
+62% +$14.2K ﹤0.01% 1893
2023
Q4
$4K Buy
+1,300
New +$22.9K ﹤0.01% 2862
2023
Q3
Sell
-600
Closed -$1K 4242
2023
Q2
$1K Buy
+600
New +$11.6K ﹤0.01% 3381
2023
Q1
Sell
-3,300
Closed -$7K 4559
2022
Q4
$7K Sell
3,300
-1,700
-34% -$38.4K ﹤0.01% 2961
2022
Q3
$13K Hold
5,000
﹤0.01% 2943
2022
Q2
$17K Buy
+5,000
New +$125K ﹤0.01% 2816
2020
Q2
Sell
-3,000
Closed -$2K 4776
2020
Q1
$2K Buy
+3,000
New +$125K ﹤0.01% 3541
2019
Q4
Sell
-2,700
Closed -$1K 4490
2019
Q3
$1K Sell
2,700
-4,200
-61% -$170K ﹤0.01% 3809
2019
Q2
$11K Sell
6,900
-3,400
-33% -$170K ﹤0.01% 2625
2019
Q1
$62K Buy
10,300
+5,500
+115% +$272K 0.01% 1294
2018
Q4
$1K Buy
4,800
+1,900
+66% +$111K ﹤0.01% 3683
2018
Q3
$73K Sell
2,900
-3,000
-51% -$216K 0.01% 1377
2018
Q2
$215K Sell
5,900
-5,900
-50% -$282K 0.02% 744
2018
Q1
$10K Buy
11,800
+4,200
+55% +$122K ﹤0.01% 2799
2017
Q4
$60K Buy
7,600
+4,900
+181% +$148K ﹤0.01% 1730
2017
Q3
$16K Sell
2,700
-3,600
-57% -$81K ﹤0.01% 3345
2017
Q2
$10K Buy
+6,300
New +$122K ﹤0.01% 4173

Other funds holding RGNX

Cutler Group's RGNX Position: Q3 2023 in Review

Cutler Group sold out of Regenxbio (RGNX) in Q3 2023, closing a stake of 1,200 shares — an estimated $23K sold.

Cutler Group first reported a position in RGNX in Q3 2017 and held it in 20 quarters. The position peaked at $422K in Q3 2018. 159 funds tracked by Wall St. Rank hold RGNX as of Q3 2023.

  • Cutler Group reported no remaining Regenxbio position as of Q3 2023 after selling out during the quarter.
  • Cutler Group sold 1,200 Regenxbio shares in Q3 2023, an estimated $23K.
  • Cutler Group first reported a position in Regenxbio in Q3 2017 and held it in 20 quarters.
  • Cutler Group's Regenxbio position peaked at $422K in Q3 2018.
  • 159 funds tracked by Wall St. Rank held Regenxbio as of Q3 2023.

Based on Cutler Group's 13F filing for Q3 2023, filed 7 Nov 2023.